FB Nasdaq FB Facebook

Pre-Market Movers: Exxon Mobil Corporation(NYSE:XOM), Advaxis, Inc.(NASDAQ:ADXS), Inteliquent Inc(NASDAQ:IQNT)

Exxon Mobil Corporation(NYSE:XOM) gained in early trading after reporting earnings that beat Wall Street estimates. The energy producer estimated that Q1 EPS declined 1% from a year earlier to $2.10, beating the consensus forecast of $1.88 measured by Capital IQ. Revenue fell 1% from the prior year to $106.8 billion, missing the analyst forecast of $111 billion. ExxonMobil rose 0.3% to $102.73 in early trading. … Continue reading Pre-Market Movers: Exxon Mobil Corporation(NYSE:XOM), Advaxis, Inc.(NASDAQ:ADXS), Inteliquent Inc(NASDAQ:IQNT)

Watch List: Qihoo 360 Technology (NYSE:QIHU), COMSCORE, Inc. (NASDAQ:SCOR), Ameriprise Financial, Inc. (NYSE:AMP), Sprint Corporation (NYSE:S)

Qihoo 360 Technology Co Ltd (NYSE:QIHU), China’s leading Internet security provider, will lease more than “tens of thousands” of servers, according to Tan Xiaosheng, vice-president of Qihoo 360 Technology Co Ltd (NYSE:QIHU). Qihoo 360 Technology Co Ltd (NYSE:QIHU) stock performance was 3.43% in last session and finished the day at $87.69. Traded volume was 2.88million shares in the last session and the average volume of … Continue reading Watch List: Qihoo 360 Technology (NYSE:QIHU), COMSCORE, Inc. (NASDAQ:SCOR), Ameriprise Financial, Inc. (NYSE:AMP), Sprint Corporation (NYSE:S)

Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)

The American Despositary Receipts of Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) edged up in recent pre-market trading on Monday after announcing over the weekend an agreement it has signed with Takeda Pharmaceutical for the marketing and sale of Rasagiline in Japan. Rasagiline is a treatment for Parkinson’s Disease developed by TEVA and has been approved in over 40 countries. TEVA closed at $48.69 on Friday in … Continue reading Biotech Pre-Market Movers: Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA), Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Pfizer Inc.(NYSE:PFE), AstraZeneca plc (ADR)(NYSE:AZN)

FB Nasdaq FB Facebook

Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott Laboratories (NYSE:ABT), UnitedHealth Group (NYSE:UNH), AstraZeneca (NYSE:AZN)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was 0.32% in last session and finished the day at $6.20. Traded volume was 4.92million shares in the last session and the average volume of the stock remained 5.60million shares. The beta … Continue reading Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott Laboratories (NYSE:ABT), UnitedHealth Group (NYSE:UNH), AstraZeneca (NYSE:AZN)

Tech Sector Most Active Stocks: Oracle Corporation (NYSE:ORCL), BlackBerry Ltd (NASDAQ:BBRY), Micron Technology (NASDAQ:MU), Facebook (NASDAQ:FB)

Recently, Argus downgraded Oracle Corporation (NYSE:ORCL) from Buy to Hold (Mar 20, 2014). Previously, Deutsche Bank upgraded ORCL from Hold to Buy. Oracle Corporation (NYSE:ORCL) rose 3.39 percent to $40.91 Monday on volume of 48.34million shares. The intra-day range of the stock was $39.63 to $41.43. Oracle Corporation (NYSE:ORCL) has a market capitalization of $182.41billion. BlackBerry Limited (NASDAQ:BBRY), a world leader in mobile communications, today … Continue reading Tech Sector Most Active Stocks: Oracle Corporation (NYSE:ORCL), BlackBerry Ltd (NASDAQ:BBRY), Micron Technology (NASDAQ:MU), Facebook (NASDAQ:FB)

ARM Holdings in Line to Meet Full Year Guidance After Solid Quarter

ARM Holdings reported strong third-quarter earnings and gave investors a solid, but not spectacular, fourth-quarter outlook that was relatively in line with our expectations. We will maintain our moat rating for ARM but may raise our fair value estimate by about 10%. Nonetheless, we still believe the company’s stock price reflects overly optimistic assumptions about long-term royalty growth, particularly from PCs and servers. ARM’s revenue … Continue reading ARM Holdings in Line to Meet Full Year Guidance After Solid Quarter